A nomogram for predicting probability of low risk of MammaPrint results in women with clinically high-risk breast cancer

We aimed to develop a prediction MammaPrint (MMP) genomic risk assessment nomogram model for hormone-receptor positive (HR+) and human epidermal growth factor receptor-2 negative (HER2–) breast cancer and minimal axillary burden (N0-1) tumors using clinicopathological factors of patients who underwe...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Young Joo, Hwang, Young Sol, Kim, Junetae, Ahn, Sei-Hyun, Son, Byung Ho, Kim, Hee Jeong, Ko, Beom Seok, Kim, Jisun, Chung, Il Yong, Lee, Jong Won, Lee, Sae Byul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8648770/
https://www.ncbi.nlm.nih.gov/pubmed/34873249
http://dx.doi.org/10.1038/s41598-021-02992-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8648770/
https://www.ncbi.nlm.nih.gov/pubmed/34873249
http://dx.doi.org/10.1038/s41598-021-02992-8

Ejemplares similares